Status epilepticus
DH Lowenstein, BK Alldredge - New England Journal of …, 1998 - Mass Medical Soc
A patient in status epilepticus has continuous or rapidly repeating seizures. Although the
danger of this pattern of seizure activity has been recognized since antiquity, our …
danger of this pattern of seizure activity has been recognized since antiquity, our …
[HTML][HTML] Harnessing cerebrospinal fluid circulation for drug delivery to brain tissues
GN Kouzehgarani, T Feldsien, HH Engelhard… - Advanced Drug Delivery …, 2021 - Elsevier
Initially thought to be useful only to reach tissues in the immediate vicinity of the CSF
circulatory system, CSF circulation is now increasingly viewed as a viable pathway to deliver …
circulatory system, CSF circulation is now increasingly viewed as a viable pathway to deliver …
[图书][B] Anestesia
RD Miller - 1993 - sanidad.gob.es
Consulta preanestésica Una sala de pre-anestesia por área quirúrgica Salas de
recuperación postanestésica susceptible de recibir pacientes de quirófanos contiguos …
recuperación postanestésica susceptible de recibir pacientes de quirófanos contiguos …
Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomised study
E Lahat, M Goldman, J Barr, T Bistritzer, M Berkovitch - Bmj, 2000 - bmj.com
Objective: To compare the safety and efficacy of midazolam given intranasally with
diazepam given intravenously in the treatment of children with prolonged febrile seizures …
diazepam given intravenously in the treatment of children with prolonged febrile seizures …
Midazolam: the first water‐soluble benzodiazepine; pharmacology, pharmacokinetics and efficacy in insomnia and anesthesia
JH Kanto - … : The Journal of Human Pharmacology and Drug …, 1985 - Wiley Online Library
Midazolam is a 1, 4‐benzodiazepine derivative with a unique chemical structure: depending
on environmental pH, the drug can produce highly water‐soluble salts (pH< 4) or exist in …
on environmental pH, the drug can produce highly water‐soluble salts (pH< 4) or exist in …
Effect of lipophilicity on drug distribution and elimination: influence of obesity
CD Bruno, JS Harmatz, SX Duan… - British Journal of …, 2021 - Wiley Online Library
Aims For a given passively‐distributed lipophilic drug, the extent of in vivo distribution
(pharmacokinetic volume of distribution, Vd) in obese individuals increases in relation to the …
(pharmacokinetic volume of distribution, Vd) in obese individuals increases in relation to the …
CSF as a surrogate for assessing CNS exposure: an industrial perspective
JH Lin - Current drug metabolism, 2008 - ingentaconnect.com
For drugs that directly act on targets in the central nervous system (CNS), sufficient drug
delivery into the brain is a prerequisite for drug action. Systemically administered drugs can …
delivery into the brain is a prerequisite for drug action. Systemically administered drugs can …
Overcoming the challenges of developing an intranasal diazepam rescue therapy for the treatment of seizure clusters
Seizure clusters must be treated quickly and effectively to prevent progression to prolonged
seizures and status epilepticus. Rescue therapy for seizure clusters has focused on the use …
seizures and status epilepticus. Rescue therapy for seizure clusters has focused on the use …
Benzodiazepines, methadone and buprenorphine: interactions and clinical management
N Lintzeris, S Nielsen - The American Journal on Addictions, 2010 - Wiley Online Library
Benzodiazepines (BZDs) are widely used by heroin users not in treatment, and by patients
in methadone and buprenorphine (BPN) treatment. This review examines the epidemiology …
in methadone and buprenorphine (BPN) treatment. This review examines the epidemiology …
Clinical pharmacokinetics of non-opiate abused drugs
U Busto, R Bendayan, EM Sellers - Clinical pharmacokinetics, 1989 - Springer
The present review discusses the available data on the kinetic properties of non-opiate
abused drugs including psychomotor stimulants, hallucinogens and CNS-depressants …
abused drugs including psychomotor stimulants, hallucinogens and CNS-depressants …